Discontinuation report ABSTRAL
Report ID | 56649 |
Drug Identification Number | 02364212 |
Brand name | ABSTRAL |
Common or Proper name | FENTANYL |
Company Name | PALADIN PHARMA INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FENTANYL |
Strength(s) | 600MCG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL |
Packaging size | 10 TABS |
ATC code | N02AB |
ATC description | OPIOIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-07-24 |
Actual discontinuation date | 2018-07-24 |
Remaining supply date | 2018-07-24 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2018-07-26 | French | Compare |
v1 | 2018-07-26 | English | Compare |
Showing 1 to 2 of 2